A Lipid‐Sensitive Spider Peptide Toxin Exhibits Selective Anti‐Leukemia Efficacy through Multimodal Mechanisms
Advanced Science · 2024-08 · 11 (32)
DOI: 10.1002/advs.202404937 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 04.07.2024. Verfasst von Peng Zhang und 16 weiteren Autor:innen. Beteiligte Einrichtung: The National & Local Joint Engineering Laboratory of Animal Peptide Drug Development, College of Life Sciences, Hunan Normal University, Changsha, Hu…. Hauptthemen laut MEDLINE: Leukemia, Mice, Nude. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Subversive Innovation Competition Project of Hunan Province, Science and Technology Innovation Program of Hunan Province, Scientific Research Program of FuRong Laboratory.
Abstract (Originalsprache)
Anti‐cancer peptides (ACPs) represent a promising potential for cancer treatment, although their mechanisms need to be further elucidated to improve their application in cancer therapy. Lycosin‐I, a linear amphipathic peptide isolated from the venom of Lycosa singorensis , shows significant anticancer potential. Herein, it is found that Lycosin‐I, which can self‐assemble into a nanosphere structure, has a multimodal mechanism of action involving lipid binding for the selective and effective treatment of leukemia. Mechanistically, Lycosin‐I selectively binds to the K562 cell membrane, likely due to its preferential interaction with negatively charged phosphatidylserine, and rapidly triggers membrane lysis, particularly at high concentrations. In addition, Lycosin‐I induces apoptosis, cell cycle arrest in the G1 phase and ferroptosis in K562 cells by suppressing the PI3K‐AKT‐mTOR signaling pathway and activating cell autophagy at low concentrations. Furthermore, intraperitoneal injection of Lycosin‐I inhibits tumor growth of K562 cells in a nude mouse xenograft model without causing side effects. Collectively, the multimodal effect of Lycosin‐I can provide new insights into the mechanism of ACPs, and Lycosin‐I, which is characterized by high potency and specificity, can be a promising lead for the development of anti‐leukemia drugs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The National & Local Joint Engineering Laboratory of Animal Peptide Drug Development, College of Life Sciences, Hunan Normal University, Changsha, Hunan, 410081, China.
- Peptide and Small Molecule Drug R&D Platform, Furong Laboratory, Changsha, Hunan, 410081, China.
- Institute of Interdisciplinary Studies, Hunan Normal University, Changsha, 410081, China.
- College of Biology, Hunan University, Changsha, Hunan, 410082, China.
- Department of Hematology, The Second Xiangya Hospital, Central South University, Changsha, Hunan, 410011, China.
- Department of Hematology, The Third Affiliated Hospital of Southern Medical University, Southern Medical University, Guangzhou, 510630, China.
ORCID-Profile: Zhonghua Liu
Förderung
- Subversive Innovation Competition Project of Hunan Province
- Science and Technology Innovation Program of Hunan Province
- Scientific Research Program of FuRong Laboratory
- National Natural Science Foundation of China
Zitieren
APA
Zhang, P., Luo, W., Zhang, Z., Lv, M., Sang, L., Wen, Y., Wang, L., Ding, C., Wu, K., Li, F., Nie, Y., Zhu, J., Liu, X., Yi, Y., Ding, X., Zeng, Y., & Liu, Z. (2024). A Lipid‐Sensitive Spider Peptide Toxin Exhibits Selective Anti‐Leukemia Efficacy through Multimodal Mechanisms. Advanced Science, 11(32). https://doi.org/10.1002/advs.202404937
Vancouver
Zhang P, Luo W, Zhang Z, Lv M, Sang L, Wen Y, et al. A Lipid‐Sensitive Spider Peptide Toxin Exhibits Selective Anti‐Leukemia Efficacy through Multimodal Mechanisms. Advanced Science. 2024;11(32). doi:10.1002/advs.202404937
BibTeX
@article{Zhang2024,
author = {Zhang, Peng and Luo, Wu and Zhang, Zixin and Lv, Mingchong and Sang, Longkang and Wen, Yuhan and Wang, Lingxiang and Ding, Changhao and Wu, Kun and Li, Fengjiao and Nie, Yueqi and Zhu, Jiaoyue and Liu, Xiaofeng and Yi, Yan and Ding, Xiaofeng and Zeng, Youlin and Liu, Zhonghua},
title = {A Lipid‐Sensitive Spider Peptide Toxin Exhibits Selective Anti‐Leukemia Efficacy through Multimodal Mechanisms},
journal = {Advanced Science},
year = {2024},
volume = {11},
number = {32},
doi = {10.1002/advs.202404937}
}
EUVIMED